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Abstract
Background: Effective prophylaxis and treatment for infections caused by biological threat agents
(BTA) rely upon early diagnosis and rapid initiation of therapy. Most methods for identifying
pathogens in body fluids and tissues require that the pathogen proliferate to detectable and
dangerous levels, thereby delaying diagnosis and treatment, especially during the prelatent stages
when symptoms for most BTA are indistinguishable flu-like signs.
Methods: To detect exposures to the various pathogens more rapidly, especially during these
early stages, we evaluated a suite of host responses to biological threat agents using global gene
expression profiling on complementary DNA arrays.
Results: We found that certain gene expression patterns were unique to each pathogen and that
other gene changes occurred in response to multiple agents, perhaps relating to the eventual
course of illness. Nonhuman primates were exposed to some pathogens and the in vitro and in vivo
findings were compared. We found major gene expression changes at the earliest times tested post
exposure to aerosolized B. anthracis spores and 30 min post exposure to a bacterial toxin.
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Conclusion: Host gene expression patterns have the potential to serve as diagnostic markers or
predict the course of impending illness and may lead to new stage-appropriate therapeutic
strategies to ameliorate the devastating effects of exposure to biothreat agents.
Background
Recent events have demonstrated that the capability to
assess exposure and infection of individuals by biological
threat agent (BTA) well in advance of onset of illness or at
various stages post-exposure could offer important diag-
nostic and therapeutic benefits. Direct pathogen identifi-
cation can be elusive since many pathogens sequester in
tissues initially. Direct pathogen methods include the
classical culture methods, immunoassay, and gene ampli-
fication of the pathogen. Although these methods are
being improved for incredibly greater sensitivity [1-3], the
efficiency of any diagnostic approach for direct pathogen
assessment depends upon the presence of agent in a small
specimen matrix. By the time detectable levels of patho-
gen are reached, it is frequently too late to halt the pro-
gression of the intractable illness [4,5]. Host responses
that occur rapidly after exposure to specific pathogenic
agents could provide the needed information for defense
against the biothreat agents at time periods when clinical
signs might include general malaise or flu-like symptoms
that would not differentiate among diverse pathogenic
agents (Additional file 1).
Correlation of the course of the infection and the disease
progression with molecular responses provides opportu-
nities to understand pathogenesis resulting from biologi-
cal agent exposure. Symptoms of exposure to biological
toxins such as Vibrio cholerae toxin (CT), Clostridium botu-
linum toxin A (BoNT-A), and Staphylococcal enterotoxin
B (SEB) include violent reactions within hours of expo-
sure and may lead to death in a few days. In contrast, Bru-
cella infection (B. melitensis 16 M) produces late-onset of
mild symptoms that persist over a long period of time.
Other bacterial pathogens, such as those causing anthrax
(B. anthracis) or plague (Yersinia pestis), induce systemic,
flu-like symptoms initially and progress to lethal shock
and death days later. In the case of viral threat agents, Ven-
ezuelan equine encephalitis (VEE) initially causes serious
illness, associated with severe malaise and an extended
recovery time. Dengue (DEN-2) patients usually recover
fully within days (< 1% mortality), but some individuals,
especially those with prior dengue exposure, may develop
dengue hemorrhagic fever (DHF). Therefore, the time
when an individual is exposed, the incubation period,
and the time of manifestation of the illness are crucial to
designing diagnostic and therapeutic strategies.
In the post-genomic period, it is no longer unrealistic to
hope that the examination of host responses, by interro-
gating large numbers of genes, could reveal unique
responses to the various BTA. However, there are a
number of obstacles yet to be overcome. Various patho-
gens may affect different tissues or cells that may not be
available for diagnostic purposes. For example, botuli-
num toxins target neuromuscular synapses and cholera
toxin aims for intestinal epithelial cells. As a first step
toward the goal, we focused on gene expression changes
in human peripheral blood mononuclear cells (PBMC)
since they could be readily obtained from an exposed
individual, thus taking advantage of their "reconnais-
sance" role. We carried out in vitro exposure to each of 8
biological threat or infectious agents. We confirmed the in
vitro results by using peripheral blood mononuclear cells
(PBMC) from nonhuman primates (NHP) exposed to a
bacterial pathogen (Bacillus anthracis) or, separately, to a
toxin (SEB) at various time points post-exposure to com-
pare findings in vitro to those seen in vivo. We have identi-
fied host gene expression patterns that can discriminate
exposure to various BTA, even at early time periods when
flu-like symptoms occur.
Methods
For the in vitro studies, the bacterial pathogens used were
Bacillus anthracis, Yersinia pestis, Brucella melitensis; toxins:
SEB, CT, BoNT-A; viruses: VEE and DEN-2.
We isolated RNA from human lymphoid cells after expo-
sure and analyzed the gene expression patterns induced
by these agents using cDNA arrays. We have not amplified
our message for gene array analysis in order to avoid PCR-
mediated bias.
Bacterial strain and growth conditions
Y. pestis
Y. pestis KIM5 Pgm negative mutant bacteria (Laboratory
stock) were grown on Brain Heart Infusion (BHI, Invitro-
gen, Rockville, MD) agar plates 30°C for 48 h. Pre-culture
of Y. pestis bacteria were grown in BHI broth at 26°C over-
night in shaker incubator at 180 rpm and were diluted 1/
25 in fresh BHI medium. The organism was then grown at
26°C for 5 h (OD 600 ~0.5) and used for infection. To
determine the MOI we counted serial dilutions of the bac-
terial culture by plating on (BHI) agar plates followed by
incubation at 30°C for 48 h.
B. anthracis
Spores were prepared from B. anthracis Ames strain
(pXO1+, pXO2+). Briefly, 5% sheep blood agar (SBA)BMC Infectious Diseases 2008, 8:104 http://www.biomedcentral.com/1471-2334/8/104
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plates were inoculated with B. anthracis Ames spores and
incubated overnight at 35°C. Several isolated colonies
were transferred to a sterile screw capped tube containing
5 ml of sterile PBS. NSM plates (New sporulation
medium: per liter added Tryptone; 3 grams. Yeast extract;
3 grams. Agar; 2 grams. Lab Lemco agar; 23 grams. 1%
MnCl2·4H2O; 1 ml) (150 × 25 mm Petri plate) was inoc-
ulated with 200 μl of prepared cell suspension. These
plates were incubated for 48 hrs at 35°C, then checked for
sporulation progress by microscopic examination. Con-
tinued incubation at room temperature was performed
until free refractive spores constituted 90–99% of total
suspension. Spores were then harvested from plates using
5 ml of sterile water. Spores were then washed 4 times in
sterile water. Spores were checked for purity by plating 10
μl in triplicate onto 5% SBA plates and incubating over-
night @ 35°C. Enumerations of spores were calculated
via CFU/ml (determination of viable spores) and also for
actual spores/ml using Petroff Hauser chamber.
B. melitensis
B. melitensis 16 M strain was grown in shaker flasks over-
night in Brucella broth at 37°C, plated on Brucella agar for
48 h at 37°C to obtain confluent growth. Bacteria were
scraped from plates in pyrogen-free, sterile 0.9% NaCl for
irrigation (saline), washed twice, concentration adjusted
in saline to the appropriate OD600.
Venezuelan Equine Encephalitis Virus (VEE)
The Trinidad (Trd) strain used in these studies is a virulent
virus of the epizootic IA/B variety of VEEV and was origi-
nally isolated from the brain of a donkey. Virus was
diluted to an appropriate concentration in Hank's buff-
ered saline solution containing 1% fetal bovine serum.
Dengue 2 Virus
DV-2 was grown and propagated in mycoplasma-free
Vero cell lines. The viral titer was determined by limiting
dilution plaque assays on Vero cells. All virus stocks and
culture supernatants used in the present study were free
from LPS and mycoplasma [6].
Isolation of cells from Human PBMC using elutriation 
methods
Leukopheresis units were obtained from volunteer donors
using the procedures outlined in our approved human use
protocol, reviewed by the established Institutional Review
Board at WRAIR. The written informed consent document
was provided to the volunteers in advance of the proce-
dure.
We obtained PBMC (74 blood draws over a period of ~2.5
years, and collected from ~8–10 AM to minimize variabil-
ity) from healthy human volunteers who had been
screened to be HIV and Hepatitis B negative, were from
19–61 years of age and both male and female. Human
monocytes and lymphocytes of peripheral blood mono-
nuclear cells were purified from leukopacks of healthy
donors by centrifugation over lymphocyte separation
medium (Organaon Tecknika, NC). Monocytes and lym-
phocytes were then further purified by counter flow cen-
trifugation-elutriation with pyrogen-free, Ca2+- and Mg2+-
free phosphate-buffered saline as the eluant. The resulting
monocytes and lymphocyte preparations had greater than
95% viability. Monocytes and lymphocytes were mixed in
the ratio 1:4 and were used immediately. Cell cultures
were maintained in RPMI media at 37°C.
Exposure of monocytes and lymphocytes to the various pathogenic 
agents
Lymphoid cells were then exposed to a pathogenic agent
under conditions (dose, exposure time) deemed optimal
for biological activity for each agent by the pathogen spe-
cialist. The multiplicity of infection (MOI) of the bacteria
or viruses to lymphoid cells was as follows: anthrax spores
(1 or 3), VEE (1 or 3), DEN-2, (0.2 or 1), Brucella (2), and
plague (20). Following a 30-min infection period cells
were washed once with Hanks Balance Salt Solution
(HBSS, Invitrogen, Rockville, MD). Both uninfected and
infected cells were maintained in RPMI Medium 1640
with 10% human AB serum at 37°C 5% CO2 for the dif-
ferent time periods post exposure. Cells were harvested
and total RNA isolated using Trizol reagent (Invitrogen,
Carlsbad, CA).
The bacterial toxins, CT (3 nM), SEB (100 ng/mL), and
BoNT-A (1 nM), were added to newly plated cells in flasks
for the time period specified. Cells, incubated in the
absence and presence of the toxins, were collected by cen-
trifugation. Trizol™ (Invitrogen, Carlsbad, CA,) was added
to the cells for RNA isolation and the cells were frozen at
-70°C until use.
RNA isolation and cDNA arrays
RNA was isolated according to the Trizol method (Invitro-
gen, Carlsbad, California) followed with DNAse digestion
[7]. The custom cDNA slides contained ~10,000 genes
(Additional file 2). Stratagene reference RNA was labeled
with Cy3 and used to compare with RNA (Cy5) from
either control or exposed samples. RNA was labeled using
Micromax-TSA labeling kits (Perkin Elmer, Boston, MA),
hybridized and scanned in an Axon scanner. GenePix 3.0
(Axon) was used to analyze the scanned image. For stud-
ies using Human cDNA membranes (Clontech Laborato-
ries, Palo Alto, California), RNA samples were labeled
with radioactive 33P. After washing, the blots were
exposed to Kodak screen and scanned in a BIORAD mul-
tifluor scanner. Atlas Image software (BD Biosciences
Clontech) was used for spot alignment and normalization
of the scanned arrays.BMC Infectious Diseases 2008, 8:104 http://www.biomedcentral.com/1471-2334/8/104
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Statistical analyses and data scrutiny
We have adhered to "MIAME" (minimum information
about microarray experiments) for all our studies. For
each pathogen, 3–6 successive time periods were studied
and for each time period, data from 2–4 separate experi-
ments were obtained and, using the data from these mul-
tiple experiments, 2-way ANOVA analysis were carried
out. GeneSpring version 5.0 (Silicon Genetics, San Carlos,
CA) and Partek Pro 5.0 (St. Charles, MO) were used to vis-
ualize and analyze the data. Welch's ANOVA (p < 0.05)
was performed followed by Benjamini Correction [8] for
various sets of data, to find genes that varied significantly
across samples and to identify patterns of gene regulation
in PBMC exposed to various pathogens. For custom
microarrays, we used the scatter plot smoother, Lowess
algorithm [9], to normalize for dye bias among samples.
We filtered the array data at 2 steps. In the first step, data
filtration allowed only elements for which intensities in
both channels were above twice background intensity. In
the second step, elements that had intensities below twice
the background intensity in one channel only were set at
twice background levels. Last, to identify patterns of gene
expression among different pathogens, k-means and self-
organizing map clustering analyses were performed.
Complete linkage hierarchical clustering of an uncentered
Pearson correlation similarity matrix was also applied
using the Eisen Cluster software [10], and the results were
visualized with the program TreeView. We have used the
major dataset (data from Figure 1b) as a training set to
apply a class prediction method (GeneSpring 6.1) that
uses the k-nearest neighborhood algorithm to classify
blinded samples used as test sets.
Feature selection, computation and classification
Extracting discrete data: We applied the Greedy algorithm
approach (46).
For each of the 8 pathogens at each time point evaluated
(29) (where a condition is the combination of a pathogen
and a time interval), we compute for each gene a regula-
tion type which is a nonempty subset of {U, D, S}. For a
given condition and gene, the regulation type contains U
(respectively D, S) if for at least one array for that condi-
tion, using either sum or median normalization tech-
(a) B. anthracis exposure to PBMC from 3 different donors Figure 1
(a) B. anthracis exposure to PBMC from 3 different donors. Data shown are from exposures at 2, 4, 8 and 24 h. Data from each 
exposure time period were separately evaluated in order to identify common trends among the three donors (males, ages 61, 
41, and 27 years old (respectively) with diverse ethnicity). (b). Comparisons of gene profiles for 8 pathogenic agents. Human 
PBMC were exposed to each of these pathogenic agents for at least 3 appropriate time periods. RNA was isolated, and the 
reverse transcript hybridized to cDNA arrays. Unique gene patterns were induced by BTAs. Cluster diagram of gene expres-
sion patterns use Gene Spring analysis to illustrate groups of genes that show discriminatory patterns for various threat agents. 
These genes were compared for their expression patterns across all agents and time points. Red is up regulated, blue is down 
regulated and black is no change compared to the control sample. The expression patterns illustrate how one can differentiate 
pathogenic agents by selection of sets of gene expression patterns for examination. (Gene accession ID numbers, rather than 
gene names, are all provided legibly in the graphs of Additional files).
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niques and either difference or ratio criteria, the gene
appears to be up regulated (respectively down regulated,
stay the same). Thus we model both variation between
donors and experimental error. The regulation type {U,
D} is treated as if it were {U, D, S}; i.e. we consider it to
provide no information.
Ordering the genes: For each value of n, we would like to
select the n genes which best distinguish between the 29
conditions. Since this is an intractable task, we compute
an approximation by ordering the genes according to a
heuristic, and for each n, choose the first n genes from the
list. There are two straightforward greedy approaches to
generating such a list. In the grow approach we start with
an empty list and at each step add the gene that gives the
new list with the best discrimination power. In the shrink
approach we generate the list in reverse order by starting
with the full set of genes and removing the one that that
leaves the remaining set with the best discrimination
power.
We estimate the discrimination power of a set of genes by
computing an integer vector of length 812, containing an
entry for each of the 29 × 28 ordered pairs of distinct con-
ditions, which itself is a sum computed over all genes in
the set. The values summed are the number of elements in
the regulation type for the first condition of the pair that
do not occur in the regulation type for the second condi-
tion. This vector is then sorted least element first. To com-
pare the discrimination power of two gene sets, their
vectors are computed and compared lexicographically,
with larger vector considered to correspond to the gene set
with better discrimination power. The first 50 genes to be
ranked by this method are listed in the Additional file 3.
In vivo anthrax exposure
Animal work was conducted in compliance with the Ani-
mal Welfare Act and other federal statutes and regulations
relating to animals and experiments involving animals
and adheres to principles stated in the Guide for the Care
and Use of Laboratory Animals, NRC Publication, 1996
edition. Nine anthrax-naïve rhesus macaque NHPs were
exposed to approximately 8 LD50 of B. anthracis spores
(Ames strain) by a head-only aerosol exposure system.
Blood was drawn before exposure to determine baseline
values. After exposure, 3 animals were euthanized at each
24, 48 and 72 h and blood taken for various analyses,
including gene response patterns. A full necropsy was per-
formed to collect biological samples for use in B. anthracis
diagnostic assay development.
Primer set design
Primer sets were designed for selected genes for expression
profile confirmation. Additional file 4 lists the accession
numbers and sequences for both sense and antisense
primers.
Real-time PCR
Total RNA from the all the pathogenic agent studies was
reverse-transcribed simultaneously using the same master
mix. The cDNA was then used to perform real-time PCR
using BIORAD I cycler and the light cycler DNA master
SYBR green I kit (Roche Diagnostics, Indianapolis, Indi-
ana). The 18S gene was used as an endogenous control to
normalize the HIF-1, GBP, and C5AR genes. Serial 10-fold
dilutions of lymphoid cDNA were used to determine the
PCR efficiency of each primer set. The slope value was
applied to the formula E = 10-1/m - 1 where m = slope
value. The Ct (threshold cycle) values for all the genes
were converted to fold change using the formula (1 +
E)ΔCt, where E denotes the efficiency of the primer set for
a gene. ΔCt denotes the difference between the Ct values
of control and treated samples of a given gene. (Personal
Communication, C. Baker, National Institutes of Health)
Results
Host gene expression in vitro
Microarray analysis was carried out at 3–6 time periods
post exposure of PBMC to each pathogen or vehicle. Prior
studies [11] showed specific gene sets related to sex, age
and other parameters, therefore it was important to first
identify genes that are normally variant among healthy
humans. Data from only the control samples of these
healthy donors were subjected to ANOVA (p =< 0.05) and
6% of the genes varied widely among the individuals who
were healthy human donors. These genes that showed
inconsistent expression profiles were excluded from fur-
ther comparisons among the data sets from both control
and exposed samples. This provided a baseline to confi-
dently identify transcriptional responses induced by bac-
teria (anthrax, plague, Brucella), toxins (CT, SEB, BoNTA),
or viruses (Dengue, VEE). Expression ratios of 10,000
genes on the custom array (accession numbers of which
are listed in Additional file 2) and genes (Additional file
5) in Human Atlas 1.2 were determined by comparing the
levels of mRNA in control and pathogen-treated PBMC
paired for each exposure time frame. Each measurement
was carried out at least 3 times.
Consistency of responses
We used PBMC from at least 3 different donors, exposing
cells to pathogen or vehicle for specified periods of time.
Figure 1a is a cluster analysis of exposures to B. anthracis
for 2, 4, 8 and 24 h exposures. The result from the 3 dif-
ferent donors (male, ages 61, 27, 41) is closely replicated
among the donors.BMC Infectious Diseases 2008, 8:104 http://www.biomedcentral.com/1471-2334/8/104
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Unique gene patterns induced by BTAs
The gene responses were dissected to identify sets of genes
that will differentiate one agent from another based on
the patterns of host gene induction. The GeneSpring (Sil-
icon Genetics, California) clustering diagram illustrates
gene expression patterns that can discriminate among the
various pathogenic agents (Fig. 1b) by identification of
sets of genes where up regulation (red) and down regula-
tion (blue) is seen for specific pathogens. The combina-
tion of these selected genes can be the foundation for
designing specific diagnostic assays for exposure to one or
more agents. For example, gene sets A and B (column
labels at the bottom of the dendogram), differentiate B.
anthracis from all other pathogenic agents except Dengue;
gene sets F and G readily illustrate expression patterns that
differentiate gene responses to these 2 pathogenic agent.
Similarly, gene sets D and E and H show host responses to
SEB that are distinguishing; BoNTA and VEE show similar
patterns with gene sets A and B, but are readily separated
by gene set C. Principal component analysis (PCA) (Fig.
2a) illustrates clustering relationships that show marked
differences in overall gene patterns among the 3 toxins
used in this study. Additionally, gene patterns for the ear-
liest exposure for SEB or CT clustered less closely with the
later exposure times (Fig. 2b), but when observed relative
to all pathogens, the four exposure time periods for SEB
were relatively closely clustered. A striking observation
(Fig. 2b) is that for all pathogens except SEB, the longest
exposure times differ markedly from the clusters of the
early time periods. For B. anthracis, Y. pestis, B. melitensis,
and CT, those late exposure times cluster together for
these various pathogens. This loss of pathogen-specific
responses in vitro after lengthy exposure was not seen for
the in vivo studies.
Use of training and test data sets for classifying test 
exposures
To determine whether the microarray data obtained in
this study can be used to predict the exposure type of an
uncharacterized sample or condition, we applied a super-
vised learning method for class prediction (GeneSpring)
that uses the k-nearest neighbor algorithm. When algo-
rithm was applied on the data set (training set) to predict
the exposure type of a data set obtained from an exposure
to Y. pestis (test set), we were able to correctly predict the
type of exposure with a p < 0.02. We previously reported
that a set of predictor genes was identified when samples
from exposures of piglets to SEB were used as test sets
[12,13].
PCA relational analysis to show how the gene profiles (various exposure times) cluster for each toxin (a) and the relationship  among the various pathogens (b) Figure 2
PCA relational analysis to show how the gene profiles (various exposure times) cluster for each toxin (a) and the relationship 
among the various pathogens (b). Human PBMC were exposed to each of these pathogenic agents for at least 3 appropriate 
time periods. RNA was isolated, and the reverse transcript hybridized to cDNA arrays.
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Functional classification of genes differentially regulated
Gene ontological analysis was carried out for the genes
that were differentially expressed. Comparison of gene
responses, based on functional similarities, not surpris-
ingly, showed many up regulated genes coding for inflam-
matory mediators (Fig. 3). We clustered and sorted the
differentially expressed genes by their functional classifi-
cation. These functional classifications are depicted in Fig-
ure 3. For gene group (i) "Growth Factor, Cytokines &
Chemokines," anthrax, Brucella and SEB showed major up
regulation of most genes coding for inflammatory media-
tors; the other 5 agents had mixed or modest effects. Sim-
ilarly, categories (iii) "Interleukins and Interferon
Receptors" and (iv) "Interleukins" showed up regulation
by most pathogens, notable exceptions being the viruses.
Down regulated genes, though seen extensively through-
out the study, displayed functional clustering for each
pathogenic agent such as (ii) "Homeostasis & detoxifica-
tion," (v) "Ligand-gated ion channels," and so forth.
Plague induced high levels of interleukin-6, macrophage
inflammatory protein-1 beta, tumor necrosis factor-alpha
(TNF-α), and granulocyte macrophage colony stimulating
factor (GM-CSF) when compared with Brucella  and
anthrax. Not surprisingly, the superantigen SEB displayed
kinetic patterns for over expression of interferon-γ, IL-2,
IL-6, MIP-1α, and GM-CSF (Fig. 3). There are major differ-
ences in expression of death receptors, homeostasis, and
caspases, examples of which include defensins and certain
oxidases (homeostasis) that are down regulated by plague
and SEB (Fig. 3, bullet ii). A large number of transcription
factors are down regulated by anthrax, Brucella, and SEB,
but plague consistently down regulated the widest range
of these genes.
Gene responses induced by BTAs in vivo; comparison with 
in vitro changes
To determine gene changes induced by BTAs in an animal
model, NHP were exposed to B. anthracis spores by aero-
sol challenge. This model has been characterized previ-
ously to mimic inhalation anthrax in humans. Blood
samples were collected 24 h, 48 h, and 72 h post exposure
(by 72 h the NHP were beginning to show signs of the ill-
ness, which progresses very rapidly to lethality). The gene
expression profiles for in vitro exposure of PBMC to
Functional categories of genes that show similarities and differences between these pathogens Figure 3
Functional categories of genes that show similarities and differences between these pathogens. Accession numbers are shown 
associated with Figure 2, Additional files. Human PBMC were exposed to each of these pathogenic agents for at least 3 appro-
priate time periods. RNA was isolated, and the reverse transcript hybridized to cDNA arrays.BMC Infectious Diseases 2008, 8:104 http://www.biomedcentral.com/1471-2334/8/104
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anthrax spores were compared with those found in iso-
lated PBMC at various time periods from NHP. Even by 24
h, a robust response was observed (Fig. 4a), showing up
regulation of genes coding for proteases; proteosome
components c2, c3, c5; various cytokines; pro-apoptotic
genes; cyclic adenosine monophosphate (cAMP)-related
kinases, cAMP regulated transcription factors; and
hypoxia inducible factor-1 (HIF-1). Down regulated genes
included tyrosine kinases, cytokine receptors, growth fac-
tors, and adenosine diphosphate (ADP) ribosylation fac-
tors. Comparison of the in vivo results with the in vitro
changes induced by anthrax (Fig. 4b), showed remarkable
similarities in gene patterns. Clearly many more changes
were observed in vivo than in vitro. Certain surface antigens
showed significant alteration that was unique to anthrax
exposure. Diagrams were constructed to identify sets of
genes that were up regulated (Fig. 5) at either 24 (blue) or
72 h (red); other gene sets showed up regulation at both
time periods (center of graph, genes in both blue and red).
Similarly, certain gene sets showed unique and common
down-regulation patterns (far right, Fig. 5).
A few genes were selected that showed changes induced by
B. anthracis exposure were confirmed by RT-PCR, and the
level of expression was compared both in vitro and in vivo
after anthrax exposure. The in vivo/in vitro trends were very
similar for many genes including IL-6 (Fig. 6a) and Trans-
ducin beta-1 subunit (GNB1) (Fig. 6b). Altered regulation
of that G-protein was not seen with the other pathogenic
agents. In an experiment of SEB exposure to NHP (Fig. 7),
IL-6 and guanylate binding protein GBP-2 were up regu-
lated (6- and 65-fold, respectively) by 30 min post-expo-
Comparison of host gene responses in vivo and in vitro exposures to anthrax Figure 4
Comparison of host gene responses in vivo and in vitro exposures to anthrax. Gene expression profiles in PBMC from healthy 
human donors exposed to anthrax spores in vitro were compared with gene expression patterns obtained in PBMC taken at 
24, 48 and 72 hr after exposure of NHP to anthrax spores by aerosol challenge. (a) Gene cluster analysis of significantly altered 
genes in vivo. (b) comparison of gene expression profile between in vivo and in vitro exposures.
A.                                
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sure and the increased expression persisted through 24 h
(the last time point tested, data not shown). Among all
the pathogens studied so far, SEB was found to be the only
pathogen to dramatically alter GBP-2.
Evaluating the gene selections
In order to evaluate the quality of the set of genes selected
by the two methods above, a set of 10 simulated samples
was generated for each condition by randomly choosing a
set of values consistent with the conditions regulation
types. Sets of samples in which values had a 10%, 20%,
30%, 40% and 50% chance of being chosen at random
were also generated. Each test sample was then classified
using the chosen set of genes by scoring it against each of
the 29 conditions. A condition scored 1 for every gene on
which its regulation type was consistent with the sample.
The test sample was considered to be classified correctly if
the condition from which it was originally generated had
the unique highest score. The results using the list of genes
obtained by the "grow" (respectively "shrink") method
are shown in Figure 8.
Comparison of gene selection approaches: Because there
is overlap between the gene types for some pairs of condi-
tions, there must exist a sample consistent with some con-
dition that cannot be classified correctly as that condition.
Nevertheless for the generated data, both approaches
obtained perfect classification at the 20% noise level for
selections of between 150 and 775 genes. Even at the 30%
noise level the grow method achieved perfect classifica-
tion with 297–305 genes and the shrink method achieved
perfect classification with 340–342 genes. Interestingly, in
the added noise cases, gene selections above a certain size
start to perform worse. This is because removing genes
that play little role in distinguishing between conditions
removes added noise without removing much discrimina-
tion power.
We have used simulated random noise perturbing the
input data samples, since we had no prior basis to assume
any specific bias in noise (direction or subset of genes). If
noise levels on a given sample were for some reason
biased toward the identified patterns of some other dis-
Clustered sets of genes to illustrate stage-specific vs. commonly expressed genes for in vivo exposures of NHP at 24, 72 h or  at both time periods Figure 5
Clustered sets of genes to illustrate stage-specific vs. commonly expressed genes for in vivo exposures of NHP at 24, 72 h or 
at both time periods.
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ease for that subject, our technique will not perform as
well as it does against random noise. Since at this point
possible bias or coloration of the noise is unknown, we
experimented with a range of noise levels, including levels
well higher than the total noise experienced in modern
gene expression platforms.
Gene profiles to discriminate control from infected 
lymphoid cells
To identify common gene profiles that existed among all
these individual donors, we used GeneSpring to identify
shared baseline expression levels of genes examined for
75 control samples. As these control datasets were sub-
jected to various analyses, after excluding normally vary-
ing genes, we noticed genes that were expressed at low
levels in the control samples but were significantly overex-
pressed in response to one or more pathogens. We
selected genes that showed a dramatic change in expres-
sion level and could be used to discriminate among the
pathogens. Gene profiles from two pathogens are shown
with BoNT-A (Fig. 9a) or B. melitensis (Fig. 9b) in which
the indicated genes readily differentiated it from the other
7 BTAs. Although some of these genes were slightly up reg-
ulated by one or more of the other pathogens, even those
few genes illustrate the possibilities of distinguishing
BoNT-A or B. melitensis from each of the other 7 patho-
gens.
Confirmation of gene changes by real-time PCR
To further confirm the expression levels of a few selected
genes, we performed semi-quantitative real-time PCR
using the same RNA samples isolated from lymphoid cells
that had been exposed to the various pathogenic agents/
vehicle and used to carry out the microarray experiments.
Gene expression for 3 selected genes are compared based
on real-time PCR along with gene array results. Expression
of GBP-2, which was significantly up regulated by expo-
sure of lymphoid cells to SEB (~10-fold by this technique
vs. 6-fold from the microarray analysis), was not altered
by any other pathogenic agents studied. Also up regula-
tion was observed for HIF-1 and C5AR by BoNTA and CT
and there was good agreement with data from the micro-
array studies (Fig. 10).
Discussion
The objective of this study was to use host gene expression
responses to aid in detection of exposure to biological
threat agents, we aimed to a) discriminate among various
pathogenic agents that start with similar flu-like symp-
toms [14] yet lead to severe illness by various routes
(Additional file 1) select sets of genes that can convinc-
ingly be used to differentiate normal from exposed sam-
ples c) identify sets of genes that could be used for very
early detection of exposure or estimating stage of illness
post-exposure and d) continue to characterize similarities
Confirmation of selected gene changes by RT-PCR with in vitro and in vivo samples for IL-6 (a) and Transducin beta-1 subunit,  GNB1, (b) Figure 6
Confirmation of selected gene changes by RT-PCR with in vitro and in vivo samples for IL-6 (a) and Transducin beta-1 subunit, 
GNB1, (b).
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and differences in host responses for in vitro exposures to
show some predictability for host gene profiles in NHP
models that replicate the illness induced in humans. In
another study, we found sets of genes from SEB exposures
in vitro also were predictive of in vivo responses in a piglet
model of SEB-induced lethal shock [12].
The approach depends on circulating lymphoid cell
mRNA responses reflecting a historical record (by their
mRNA responses) of encounters with pathogenic agents.
Use of unique gene patterns for diagnosis has been shown
for certain cancers [15-17]; another study showed that var-
ious pathogens induced unique gene responses in lym-
phocytes [18] and in dendritic cells [19]. To minimize
variability as reported [11] in baseline gene expression
among donors, in our study blood was collected at the
same time of the day for all donors. Of the 8 pathogenic
agents in this study, most have been characterized as hav-
ing rapid effects on lymphoid cells [14,20]. For BoNT-A
and VEE, the primary target tissues are inaccessible,
although VEE has been shown to interact with lymphoid
cells [21]. The gene expression data suggest that pathogen
binding to specific receptors on the human PBMC initi-
ates a series of events that contribute to the ultimate ill-
ness, producing host responses indicative of a particular
pathogenic agent (Additional file 6) or showing common
responses typical of a severe inflammatory reaction (Fig.
3).
The kinetics of the course of the infection and the disease
process is essential in the study of gene changes induced
in the host by these pathogens (Additional file 6). Upon
inhalation of Y. pestis by NHP, infected alveolar macro-
phages migrate to the liver and spleen [22,23] where they
proliferate rapidly (~24 h). It is thought that LPS from the
bacterial cell wall of Y. pestis (Gram-negative) induces cir-
culatory collapse and widespread organ failure, leading to
death within days [24]. SEB, CT, and LPS can induce rapid
onset of illness (even less than 1 h), involving loss of reg-
ulation of vascular tone, vascular leakage and end-stage
organ failure, in 1 to 3 days [14,25,26]. B. anthracis
(Gram-positive) is transmitted as spores, which, upon
inhalation, become engulfed by macrophages and trans-
ported to lymph nodes [20,27-31]. Upon production of a
sufficient bacterial load, flu-like symptoms occur fol-
lowed by sudden onset of respiratory distress, progressive
shock, and death. As recent events have demonstrated,
with cases of inhalation anthrax, treatments initiated after
patients became seriously symptomatic can be marginally
successful [27]. In this study, host gene expression
responses in NHP to B. anthracis exposure were seen at the
earliest time point examined, 24 h (Fig. 4b). In contrast,
in these same NHP, a sufficient pathogen load to be iden-
tified by culture techniques did not occur until day 3 and
clinical diagnosis would not be possible until ~ day 4–5,
much too late to initiate reliably effective treatments.
Studies of pathogenesis show up regulated cytokine genes
as a common response for many pathogens [14,32] and
that would not, necessarily, distinguish among them (Fig
3). Therefore, we focused on host responses that may
potentially identify stage-specific targets and can also
serve as early diagnostic markers. The regulation of certain
early genes is transient and may relate to factors that par-
ticipate in recruitment of monocytes to the sites of infec-
tion. The genes that are expressed late relate to DNA
damage-inducing proteins, hypoxia-inducible proteins,
and proteases. Characterization of apoptosis as a result of
exposure was reported for SEB, DEN-2 [33], plague [34],
and anthrax [20,27,35] in numerous cell types, including
those of lymphoid origin. We observed induction of
apoptotic genes by these agents in our studies (Additional
file 6). In contrast, Brucellae is known to inhibit apoptosis
in their mononuclear phagocytic host cells [36] and we
also observed pro-apoptotic genes to be down regulated
by Brucella. In regard to the findings with plague expo-
sure, it is important to note that these infections occurred
under conditions that limit the ability of Yersinia outer
proteins (YOP) to alter host cell physiology by down reg-
ulation of cytokines [34] and oxygen radicals [37] in cal-
cium-free cultures of macrophages. We observed up
Expression of GBP-2 and IL-6 genes after in vivo SEB expo- sure of NHP for 30 min Figure 7
Expression of GBP-2 and IL-6 genes after in vivo SEB expo-
sure of NHP for 30 min. Gene expression profiles in PBMC 
from NHP exposed to SEB for 30 min. RNA samples were 
isolated and used in the PCR assays using primers specific for 
IL-6 and GBP-2.
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regulation of certain cytokines after 1–2 hr of exposure to
Y. pestis and a pattern of gene expression that can explain
reduced synthesis of oxygen radicals. We suspect that dif-
ferent biochemical mechanisms contribute to pathogene-
sis when YOPs are produced [38,39].
In contrast to common infectious diseases, human cases
of exposure to some of the biological threat agents are
rare. Indeed, for certain of these pathogens, there is no
appropriate animal model that replicates the illness as it
appears in humans. Furthermore, dose effects and other
variations suggest the need to investigate in vitro
approaches that show some correlations to in vivo find-
ings. For in vivoB. anthracis studies, PBMC from the spore-
exposed animals was collected 24, 48, and 72 h. The in
vitro study utilized PBMC (from healthy donors) exposed
to spores for various time periods. We found many more
gene expression changes in vivo than in vitro, perhaps
because in vivo changes include both primary and second-
ary responses. Comparisons of in vitro/in vivo results
showed similarities in genes that code for lymphoid
receptors/signaling pathways that, when taken as a group,
showed a pattern specific for B. anthracis and include a G-
protein Transducin beta subunit (GNB1), cAMP related
genes, Calmodulin regulated genes, cytokines and
MAPKK (mitogen activated protein kinase kinase), some
of which had previously been reported in response to
anthrax exposures [40]. Not unexpectedly, genes coding
for cytokines showed similarities in vitro vs in vivo (Fig 5
and 6). Our microarray data were in accordance with
recent reports by Pickering et al. that showed up regula-
tion of some of the cytokines in response to infection by
B. anthracis spores including TNF-α, IL-8, IL-1β, GM-CSF,
IFN-γ and IL-6 [41]. However, these genes, alone, would
not necessarily distinguish anthrax from other pathogens.
In general, the genes expressed by 4 h in vitro and 72 h in
vivo were similar and correlated to the symptoms that
appear after progression of inhalation anthrax in NHP.
Aerosol challenge of SEB in NHPs up regulated (65-fold)
the gene coding for interferon-regulated GBP-2 (Fig. 7)
but in vitro (Figure 10) it was up-regulated 10-fold. In vivo,
GBP-2 upregulation occurred by 15 min post exposure.
Other pathogens showed minor or no effects on the
expression of that particular G-protein (Figure 10). This
may not be surprising in light of seminal studies showing
Ordered genes and resulting percentage correct classifications Figure 8
Ordered genes and resulting percentage correct classifications. For a given number of genes, a set of genes most able to dis-
criminate between disease states is selected. Simulations of noisy readings of patient gene expression levels are performed for 
varying levels of noise. Each colored line plots the percentage of correct classifications versus the number of genes used to 
make the classification for one particular percentage of random values in the simulated readings. With no noise, very few genes 
are required to discriminate perfectly. With high noise levels (say, 50%), even 1000 genes cannot reliably discriminate well.BMC Infectious Diseases 2008, 8:104 http://www.biomedcentral.com/1471-2334/8/104
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that CT and pertussis toxin work through different gua-
nine triphosphate (GTP)-binding proteins to regulate
intracellular cAMP levels [42,43]. This study confirmed
gene expression responses induced by CT, anthrax, and
Brucella that are known participants in regulation of ade-
nylyl cyclase as well as those relating to ADP ribosylation
factor [44-46] (Additional file 6). We observed a down
regulation of the host adenylyl cyclase but an up regula-
tion of cAMP-related genes upon anthrax exposure in
NHP samples (Figure 4a). Because B. anthracis has its own
adenylyl cyclase, it may be playing a role in affecting
cAMP-related genes of the host [29,47].
Expression patterns of genes that were at baseline levels in all controls and showed unique expression patterns in (a) BoNT-A  exposures or (b) B. melitensis exposures compared to all 8 pathogens Figure 9
Expression patterns of genes that were at baseline levels in all controls and showed unique expression patterns in (a) BoNT-A 
exposures or (b) B. melitensis exposures compared to all 8 pathogens.
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Real-time PCR determination of gene expression in response to each of 8 pathogenic agents. Primers were designed for these 
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fied as being massively up regulated by SEB using differential display PCR (Mendis, et al) and was of particular interest to us.
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Since most biothreat pathogen exposures start with flu-
like symptoms, discriminating them from common path-
ogenic illnesses for early diagnosis at a treatable stage is
one of the critical issue. Even though these 8 pathogens
initially cause similar symptoms, such as malaise, fever,
headache, and cough, unique sets of genes are induced by
each and can be related to the course of illness [14] (Addi-
tional files 1 and 6). Using these signature gene profiles to
assess possible exposure to pathogenic agents or to differ-
entiate them from non-lethal illnesses, when the classical
identification of a pathogen is not conclusive, has the
potential to fill a gap in the arsenal of diagnostic tools.
Conclusion
Rapid detection, before the symptoms appear or even at
various stages of illness offers the opportunity to initiate
stage-specific therapeutic approaches to ameliorate the
devastating results of these pathogenic agents. The use of
host genomic markers offers an option to differentiate
classes of pathogen exposure, gauge severity of impending
illness and apply appropriate therapeutic strategies.
1Genes were selected and their expression profiles com-
pared with gene array and real-time PCR. 18S was used as
a reference gene for comparison of these 3 test genes.
2GBP-2 was a gene that was identified as being massively
up regulated by SEB using differential display PCR (C.
Mendis, et al).
nd = not determined
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Additional material
Additional file 1
Comparison of time course of progression of illness for selected BTAs and 
pathogens: Graph courtesy of COL George Korch, USAMRIID, Ft. Det-
rick, Maryland. Hatched marks indicate onset of flu-like symptoms (fever, 
headache, chills) for each agent, X indicates time frame in which death 
usually occurs (case fatality rate, CFR), and the number of Xs suggest the 
degree of lethality if untreated early in the course of illness. (i) The toxins 
(yellow bars) cause onset of acute illness within a few hours, but side 
effects can persist for many weeks. (ii) Bacterial BTAs (pink bars) follow 
different time course after infection ranging from days to weeks. Many 
bacterial infections begin with flu-like symptoms, but proceed to respira-
tory distress and lethal shock within ~ a week. In contrast, a prolonged ill-
ness is common in brucellosis, which is caused by Gram-negative bacteria 
(B. melitensis. B. suis, and B. abortus) that are highly infectious via 
aerosol route. (iii) Viruses (green bars) VEE and DEN infections each 
progress differently because VEE can proceed to the meninges of the brain, 
developing into encephalitis. In the case of dengue, the incubation period 
is 3 to 15 days, with the acute febrile illness lasting 3–5 days. The period 
of mortality is associated with cessation of the febrile illness or with sec-
ondary complications in DHF.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2334-8-104-S1.eps]
Additional file 2
A list of genes on the custom array. This table shows a list of the genes that 
are present on the microarrays used in this study.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2334-8-104-S2.pdf]
Additional file 3
List of the first 50 genes that were selected using the Grow/Shrink method. 
This table lists the genes that passed the statistical analysis using the 
Grow/Shrink method.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2334-8-104-S3.pdf]
Additional file 4
List of the accession numbers and sequences of the primer sets used in this 
study.
Click here for file
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2334-8-104-S4.pdf]
Additional file 5
Lists the genes of the Clontech 1.2 human array.
Click here for file
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